Literature DB >> 7329441

The effect of temperature and antimetabolites on antibody binding to the outer surface of second stage Toxocara canis larvae.

H V Smith, R Quinn, J R Kusel, R W Girdwood.   

Abstract

In vitro maintained second stage Toxocara canis larvae do not bind antiserum raised to their excretions and secretions (ES) at 37 degrees C as detected by indirect fluorescence. However, when these larvae were incubated at 2 degrees C under the same conditions intense fluorescence on the whole outer surface was observed. This fluorescence remained as long as the larvae were maintained at 2 degrees C. When these larvae were reincubated at 37 degrees C a gradual loss of fluorescence along their outer surfaces occurred. This loss was complete after 3 h. Larvae which were preincubated in antimetabolites at 37 degrees C exhibited intense fluorescence on their outer surfaces as did those incubated at 2 degrees C with antimetabolites. It is concluded that antigens present in ES occur along the whole length of the larval outer surface and turn over at 37 degrees C. This turnover occurs along the whole outer surface and is metabolically dependent. Should this occur in vivo it could afford the parasite with a mechanism for evasion of the immune response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7329441     DOI: 10.1016/0166-6851(81)90017-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  18 in total

1.  Use of fluorescent lectin binding to distinguish Teladorsagia circumcincta and Haemonchus contortus eggs, third-stage larvae and adult worms.

Authors:  Katharina Hillrichs; Thomas Schnieder; Andrew B Forbes; David C Simcock; Kevin C Pedley; Heather V Simpson
Journal:  Parasitol Res       Date:  2011-07-06       Impact factor: 2.289

2.  Antigenic relationships between the surface-exposed, secreted and somatic materials of the nematode parasites Ascaris lumbricoides, Ascaris suum, and Toxocara canis.

Authors:  M W Kennedy; F Qureshi; E M Fraser; M R Haswell-Elkins; D B Elkins; H V Smith
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  Characterization of a Toxocara canis species-specific excretory-secretory antigen (TcES-57) and development of a double sandwich ELISA for diagnosis of visceral larva migrans.

Authors:  R D Iddawela; R P V J Rajapakse; N A N D Perera; Takeshi Agatsuma
Journal:  Korean J Parasitol       Date:  2007-03       Impact factor: 1.341

4.  Misinterpretation of toxocaral serodiagnostic tests.

Authors:  H V Smith; R W Girdwood; J R Kusel
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-21

5.  An abundantly expressed mucin-like protein from Toxocara canis infective larvae: the precursor of the larval surface coat glycoproteins.

Authors:  D Gems; R M Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

6.  Experimental ocular toxocariasis: a mouse model.

Authors:  S Y Ghafoor; H V Smith; W R Lee; R Quinn; R W Girdwood
Journal:  Br J Ophthalmol       Date:  1984-02       Impact factor: 4.638

7.  The production of human A and B blood group like substances by in vitro maintained second stage Toxocara canis larvae: their presence on the outer larval surfaces and in their excretions/secretions.

Authors:  H V Smith; J R Kusel; R W Girdwood
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

Review 8.  Anisakis simplex: from obscure infectious worm to inducer of immune hypersensitivity.

Authors:  M Teresa Audicana; Malcolm W Kennedy
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  Ocular larva migrans: a case report.

Authors:  R W Lyness; O E Earley; W C Logan; D B Archer
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

10.  Light and electron microscopy studies on Onchocerca jakutensis and O. flexuosa of red deer show different host-parasite interactions.

Authors:  A Plenge-Bönig; M Krömer; D W Büttner
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.